Grey Wolf Animal Health Corp. (TSXV:WOLF)

Market Cap	53.34M +95.3%
Revenue (ttm)	35.76M +33.3%
Net Income	1.66M +135.1%
EPS	0.05 +142.3%
Shares Out	34.19M
PE Ratio	32.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72,400
Average Volume	40,597
Open	1.650
Previous Close	1.650
Day's Range	1.550 - 1.650
52-Week Range	0.900 - 1.760
Beta	0.44
RSI	54.88
Earnings Date	May 1, 2026

About Grey Wolf Animal Health

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under t...

• Industry: Personal Services
• Sector: Consumer Discretionary
• CEO: Angela Cechetto
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: WOLF

Financial Performance

In 2025, Grey Wolf Animal Health's revenue was 35.76 million, an increase of 33.30% compared to the previous year's 26.83 million. Earnings were 1.66 million, an increase of 135.11%.